(IAK) U.S. Insurance - Overview
Etf: Insurance, Equities
Dividends
| Dividend Yield | 1.71% |
| Yield on Cost 5y | 3.62% |
| Yield CAGR 5y | 5.07% |
| Payout Consistency | 94.4% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.5% |
| Relative Tail Risk | 2.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.24 |
| Alpha | -2.49 |
| Character TTM | |
|---|---|
| Beta | 0.511 |
| Beta Downside | 0.575 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.38% |
| CAGR/Max DD | 1.06 |
Description: IAK U.S. Insurance December 25, 2025
The iShares U.S. Insurance ETF (IAK) seeks to replicate the performance of its underlying insurance index by holding at least 80% of its assets in the index’s component securities or securities with substantially identical economic characteristics. The remaining 20% may be allocated to futures, options, swaps, cash, or non-index securities that BlackRock believes will improve tracking efficiency. Because the fund is classified as non-diversified, its holdings are concentrated within the U.S. insurance sector.
Key metrics to watch: the fund’s expense ratio is 0.43%, and its top holdings typically include major insurers such as Chubb Ltd., The Travelers Companies, and The Hartford Financial Services. Performance is highly sensitive to interest-rate movements (which affect insurers’ investment income) and the underwriting cycle, with combined ratio trends serving as a leading indicator of profitability. As of the latest quarter, the ETF’s assets under management (AUM) exceeded $4 billion, reflecting strong investor demand for exposure to a sector that benefits from rising rates and stable premium growth.
For a deeper dive into how IAK’s risk-adjusted returns compare to peers, you might explore ValueRay’s analytical tools for a more granular view of sector dynamics.
What is the price of IAK shares?
Over the past week, the price has changed by +2.68%, over one month by +0.86%, over three months by +6.71% and over the past year by +7.07%.
Is IAK a buy, sell or hold?
What are the forecasts/targets for the IAK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 155.4 | 13.8% |
IAK Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 435.4m USD (435.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 435.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 435.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.80% (E(435.4m)/V(435.4m) * Re(7.80%) + (debt-free company))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)